Avita Pharmacy

avitapharmacy.com

Avita Pharmacy
Avita is a national health care services organization that offers a full suite of sexual wellness, pharmacy, and 340B management solutions.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

RESEARCH

PFIZER/BIONTECH WEREN'T ALONE: MODERNA COVID-19 VACCINE DATA AIMED IN EMA CYBERATTACK

Moderna | December 16, 2020

news image

It would appear that Pfizer and BioNTech's COVID-19 immunization was not the sole objective of a new cyberattack at the European Medicines Agency. Moderna said Monday that reports from its pre-accommodation conversations with EMA about its shot, mRNA-1273, were "unlawfully gotten to" by programmers, refering to a warning from the organization. The assailants didn't get individual data about preliminary members, Moderna said. The organization's ...

Read More

UROGEN PHARMA ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

Business Wire | March 06, 2020

news image

UroGen Pharma Ltd. a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options, today announced the grants of inducement restricted stock units (“RSUs”) to seventy-six new employees in connection with their employment with Urogen. These new team members will support the Company as it prepares for potential approval and commercial launch of its first product candidate....

Read More

RESEARCH

PLURISTEM ENTERS COLLABORATION WITH PHARMACEUTICAL COMPANY INNOVARE R&D TO EXPAND PLURISTEM’S ARDS ASSOCIATED WITH COVID-19 PROGRAM TO MEXICO

Pluristem | December 30, 2020

news image

Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a main regenerative medication organization building up a foundation of novel natural helpful items, reported today it has gone into a coordinated effort concurrence with Mexican drug organization Innovare R&D to extend its continuous clinical program of PLX cells in the treatment of Acute Respiratory Distress Syndrome (ARDS) related with COVID-19 in Mexico. The Phase II investigation in Mexico is dependent upon the endorsement of neighb...

Read More

PHARMA TECH

CALYX NAMED MEDICAL IMAGING PROVIDER BY CLINSCIENCE

Calyx | June 10, 2022

news image

Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, announced it has been named an approved provider of centralized medical imaging services by Clinscience, a full service CRO offering smart, end-to-end clinical trial services to the global pharmaceutical industry. "Calyx's commitment to reliably solving the complex aligns with our focus on designing integrated, smart...

Read More
news image

RESEARCH

PFIZER/BIONTECH WEREN'T ALONE: MODERNA COVID-19 VACCINE DATA AIMED IN EMA CYBERATTACK

Moderna | December 16, 2020

It would appear that Pfizer and BioNTech's COVID-19 immunization was not the sole objective of a new cyberattack at the European Medicines Agency. Moderna said Monday that reports from its pre-accommodation conversations with EMA about its shot, mRNA-1273, were "unlawfully gotten to" by programmers, refering to a warning from the organization. The assailants didn't get individual data about preliminary members, Moderna said. The organization's ...

Read More
news image

UROGEN PHARMA ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

Business Wire | March 06, 2020

UroGen Pharma Ltd. a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options, today announced the grants of inducement restricted stock units (“RSUs”) to seventy-six new employees in connection with their employment with Urogen. These new team members will support the Company as it prepares for potential approval and commercial launch of its first product candidate....

Read More
news image

RESEARCH

PLURISTEM ENTERS COLLABORATION WITH PHARMACEUTICAL COMPANY INNOVARE R&D TO EXPAND PLURISTEM’S ARDS ASSOCIATED WITH COVID-19 PROGRAM TO MEXICO

Pluristem | December 30, 2020

Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a main regenerative medication organization building up a foundation of novel natural helpful items, reported today it has gone into a coordinated effort concurrence with Mexican drug organization Innovare R&D to extend its continuous clinical program of PLX cells in the treatment of Acute Respiratory Distress Syndrome (ARDS) related with COVID-19 in Mexico. The Phase II investigation in Mexico is dependent upon the endorsement of neighb...

Read More
news image

PHARMA TECH

CALYX NAMED MEDICAL IMAGING PROVIDER BY CLINSCIENCE

Calyx | June 10, 2022

Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, announced it has been named an approved provider of centralized medical imaging services by Clinscience, a full service CRO offering smart, end-to-end clinical trial services to the global pharmaceutical industry. "Calyx's commitment to reliably solving the complex aligns with our focus on designing integrated, smart...

Read More